Evidence map›Paper›PMID 34451851›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

An Improved LC-MS/MS Method for the Analysis of Thirteen Cytostatics on Workplace Surfaces.

Maria Francisca Portilha-Cunha, Sara Ramos, Adrián M T Silva, Pedro Norton, Arminda Alves, Mónica S F Santos

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria Francisca Portilha-CunhaLEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal.ORCID 0000-0001-7069-0500
Sara RamosInstituto de Saúde Pública, Universidade do Porto, Rua das Taipas 135, 4050-600 Porto, Portugal.ORCID 0000-0002-1691-0696
Adrián M T SilvaLaboratory of Separation and Reaction Engineering-Laboratory of Catalysis and Materials (LSRE-LCM), Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal.ORCID 0000-0001-8551-6353
Pedro NortonDepartamento de Saúde Ocupacional, Centro Hospitalar Universitário São João, 4200-319 Porto, Portugal.ORCID 0000-0001-5878-116X
Arminda AlvesLEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal.
Mónica S F SantosLEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal.ORCID 0000-0001-8684-0147

Funding

European Regional Development Fund POCI-01-0145-FEDER-031297Fundação para a Ciência e a Tecnologia POCI-01-0145-FEDER-031297Fundação para a Ciência e a Tecnologia UIDB/00511/2020Fundação para a Ciência e a Tecnologia UIDB/50020/2020Ministério da Ciência, Tecnologia e Ensino Superior POCI-01-0145-FEDER-031297Ministério da Ciência, Tecnologia e Ensino Superior UIDB/00511/2020Ministério da Ciência, Tecnologia e Ensino Superior UIDB/50020/2020
6 · The paper itself

Abstract

Cytostatics are drugs used in cancer treatment, which pose serious risks to healthcare workers. Dermal absorption via surface contamination is the key exposure route; thus, rapid, reliable, and validated analytical methods for multicomponent detection are crucial to identify the exposure risk. A surface-wipe-sampling technique compatible with hospitals' safety requirements (gauze, 1 mL isopropanol) and a fast and simple extraction method (1 mL acetonitrile, 20 min ultrasonic bath, evaporation, reconstitution in 200 µL acetonitrile), coupled with liquid chromatography-tandem mass spectrometry analysis, were developed. It allowed identification and quantification of 13 cytostatics on surfaces: cyclophosphamide, doxorubicin, etoposide, ifosfamide, paclitaxel, bicalutamide, capecitabine, cyproterone, flutamide, imatinib, megestrol, mycophenolate mofetil, prednisone. Good linearity, sensitivity, and precision were achieved (R

Indexed as

analytical methodantineoplastic drugscytotoxic drugsenvironmental contaminationhealthcare workersoccupational exposuresurface contaminationwipe sampling

Identifiers

PMID34451851
PMCPMC8398795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.